Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Belite Bio Inc ADR
BLTECurrent price
82.81 USD
-0.79 USD (-0.94%)
Last closed
83.66 USD
Company
belitebio.com
ISIN
US07782B1044
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 482 053 376 USD
Yield for 12 month
+122.67 %
1Y
3Y
5Y
10Y
15Y
BLTE
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States. The company's lead product candidate is LBS-008 (Tinlarebant), an orally administered once-a-day tablet for maintaining the health and integrity of retinal tissues in autosomal recessive Stargardt disease and geographic atrophy patients. It is also developing LBS-009, an anti-retinol binding protein 4 oral therapy that is in the preclinical development phase targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc is a subsidiary of Lin Bioscience International Ltd. Address: 12750 High Bluff Drive, San Diego, CA, United States, 92130
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
56.75 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-399 000 USD
Last Year
-198 000 USD
Current Quarter
–
Last Quarter
–
Key Figures BLTE
1 year
3 years
5 years
10 years
EBITDA
-36 538 500 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-25.62 %
PEG Ratio
–
Return On Equity TTM
-41.44 %
Wall Street Target Price
56.75 USD
Revenue TTM
–
Book Value
3.74 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.23 USD
Diluted Eps TTM
-1.23 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics BLTE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BLTE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation BLTE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-35.6078
Price Book MRQ
21.6597
Financials BLTE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BLTE
For 52 weeks
31.01 USD
83.6 USD
50 Day MA
55.9 USD
Shares Short Prior Month
273 467
200 Day MA
47.91 USD
Short Ratio
6.93
Shares Short
270 587
Short Percent
2.14 %
BeatStart